Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Type
1.2.2. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources & Third-Party Perspectives
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.2.1. Market Driver Analysis
3.2.1.1. Increase in number of needlestick injuries
3.2.1.2. Rising vaccination rates and campaigns
3.2.1.3. Advancements in hypodermic syringes and needles
3.2.2. Market Restraint Analysis
3.2.2.1. Product recalls and field safety notices
3.2.2.2. Adverse effects associated with hypodermic needles
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenges Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
Chapter 4. Product Type Business Analysis
4.1. Product Segment Dashboard
4.2. Europe Hypodermic Syringes and Needles Market: Product Type Movement Analysis
4.3. Europe Hypodermic Syringes and Needles Market Size & Trend Analysis, by Product Type, 2018 - 2030 (USD Million)
4.4. Hypodermic Syringes
4.4.1. Hypodermic Syringes Market, 2018 - 2030 (USD Million)
4.4.2. Conventional Syringes
4.4.2.1. Conventional Syringes Market, 2018 - 2030 (USD Million)
4.4.3. Safety Syringes
4.4.3.1. Safety Syringes Market, 2018 - 2030 (USD Million)
4.4.3.2. Retractable Safety Syringes
4.4.3.2.1. Retractable Safety Syringes Market, 2018 - 2030 (USD Million)
4.4.3.3. Non-retractable Safety Syringes
4.4.3.3.1. Retractable Safety Syringes Market, 2018 - 2030 (USD Million)
4.5. Hypodermic Needles
4.5.1. Hypodermic Needles Market, 2018 - 2030 (USD Million)
4.5.2. Conventional Needles
4.5.2.1. Conventional Needles Market, 2018 - 2030 (USD Million)
4.5.3. Safety Needles
4.5.3.1. Safety Needles Market, 2018 - 2030 (USD Million)
Chapter 5. End Use Business Analysis
5.1. End Use Segment Dashboard
5.2. Europe Hypodermic Syringes and Needles Market: End-use Movement Analysis
5.3. Europe Hypodermic Syringes and Needles Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
5.4. Hospitals
5.4.1. Hospitals Market, 2018 - 2030 (USD Million)
5.5. Clinics
5.5.1. Clinics Market, 2018 - 2030 (USD Million)
5.6. Ambulatory Surgical Centers
5.6.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
5.7. Veterinary
5.7.1. Veterinary Market, 2018 - 2030 (USD Million)
5.8. Home Care
5.8.1. Home Care Market, 2018 - 2030 (USD Million)
5.9. Others
5.9.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Europe Hypodermic Syringes and Needles Market: Regional Estimates & Trend Analysis by Product Type, End Use
6.1. Regional Dashboard
6.2. Market Size and Trend Analysis, 2018 to 2030
6.3. Europe
6.3.1. Europe hypodermic syringes and needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.2. U.K.
6.3.2.1. Key country dynamics
6.3.2.2. Competitive scenario
6.3.2.3. Regulatory framework
6.3.2.4. Reimbursement scenario
6.3.2.5. U.K. hypodermic syringes and needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.3. Ireland
6.3.3.1. Key country dynamics
6.3.3.2. Competitive scenario
6.3.3.3. Regulatory framework
6.3.3.4. Reimbursement scenario
6.3.3.5. Ireland hypodermic syringes and needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.4. Denmark
6.3.4.1. Key country dynamics
6.3.4.2. Competitive scenario
6.3.4.3. Regulatory framework
6.3.4.4. Reimbursement scenario
6.3.4.5. Denmark hypodermic syringes and needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.5. Finland
6.3.5.1. Key country dynamics
6.3.5.2. Competitive scenario
6.3.5.3. Regulatory framework
6.3.5.4. Reimbursement scenario
6.3.5.5. Finland hypodermic syringes and needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.6. Iceland
6.3.6.1. Key country dynamics
6.3.6.2. Competitive scenario
6.3.6.3. Regulatory framework
6.3.6.4. Reimbursement scenario
6.3.6.5. Iceland hypodermic syringes and needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.7. Norway
6.3.7.1. Key country dynamics
6.3.7.2. Competitive scenario
6.3.7.3. Regulatory framework
6.3.7.4. Reimbursement scenario
6.3.7.5. Norway hypodermic syringes and needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Key country dynamics
6.3.8.2. Competitive scenario
6.3.8.3. Regulatory framework
6.3.8.4. Reimbursement scenario
6.3.8.5. Sweden hypodermic syringes and needles market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Company Market Position Analysis
7.3. Strategy Mapping
7.4. Company Profiles/Listing
7.4.1. BD (Becton, Dickinson & Corporation)
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Service Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Cardinal Health
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Service Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. B. Braun SE
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Service Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. ICU Medical
7.4.4.1. Overview
7.4.4.2. Financial Performance
7.4.4.3. Service Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Terumo Corporation
7.4.5.1. Overview
7.4.5.2. Financial Performance
7.4.5.3. Service Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Nipro Europe Group Companies (Nipro Corporation)
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Service Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. SolM
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Service Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. GBUK Group Ltd.
7.4.8.1. Overview
7.4.8.2. Financial Performance
7.4.8.3. Service Benchmarking
7.4.8.4. Strategic Initiatives



List of Figures

List of Figures

Fig. 1 Europe hypodermics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Market snapshot (regional)
Fig. 8 Product and end use segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Market dynamics
Fig. 1 Breakdown of needlestick injury claims reported to NHS 2012 - 2022
Fig. 2 COVID-19 and flu vaccinations of frontline healthcare workers in the NHS Electronic Staff Record (ESR) in England from September 11, 2023, to January 24, 2024
Fig. 3 Pharma drug pipelines for a few European countries as of December 2022
Fig. 4 Porter’s five forces analysis
Fig. 5 PESTLE analysis
Fig. 6 Hypodermics market: Product outlook and key takeaways
Fig. 7 Hypodermics market: Product movement analysis
Fig. 8 Diabetes estimates (20 - 79 y) in thousand
Fig. 9 Hypodermic needles market estimates and forecast, 2018 - 2030 USD Million
Fig. 10 Hypodermic syringes market estimates and forecast, 2018 - 2030 USD Million
Fig. 11 Hypodermics market: End use outlook and key takeaways
Fig. 12 Hypodermics market: End Use movement analysis
Fig. 13 Hospitals market estimates and forecast, 2018 - 2030 USD Million
Fig. 14 Clinics market estimates and forecast, 2018 - 2030 USD Million
Fig. 15 Ambulatory surgical centers market estimates and forecast, 2018 - 2030 USD Million
Fig. 16 Veterinary market estimates and forecast, 2018 - 2030 USD Million
Fig. 17 Home care market estimates and forecast, 2018 - 2030 USD Million
Fig. 18 Others market estimates and forecast, 2018 - 2030 USD Million
Fig. 19 Hypodermics market revenue by country, 2023 & 2030 (USD Million)
Fig. 20 Key country dynamics
Fig. 21 UK hypodermics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Key country dynamics
Fig. 23 Ireland hypodermics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Key country dynamics
Fig. 25 Denmark hypodermics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Key country dynamics
Fig. 27 Finland hypodermics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Key country dynamics
Fig. 29 Iceland hypodermics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Key country dynamics
Fig. 31 Norway hypodermics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Key country dynamics
Fig. 33 Sweden hypodermics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Key company categorization
Fig. 35 Company share analysis (%)

List of Tables

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Europe hypodermics market revenue estimates and forecast, by product, 2018 - 2030 (USD Million)
Table 4 Europe hypodermics market revenue estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Table 5 Key companies/organizations